Publications by authors named "Isabelle Cohen-Codar"

Claim this Profile
R
Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy.
Tu-Anh Tran, Jade Ghosn, Véronique Avettand-Fenoël, Houria Hendel-Chavez, Marie-Ghislaine de Goër de Herve, Isabelle Cohen-Codar

J Antimicrob Chemother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length Gag-protease genes.
Katherine A Sutherland, Jean L Mbisa, Jade Ghosn, Marie-Laure Chaix, Isabelle Cohen-Codar

J Antimicrob Chemother· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
Sidonie Lambert-Niclot, Bernard Masquelier, Isabelle Cohen Codar, Cathia Soulie, Constance Delaugerre

J Antimicrob Chemother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen.
Jade Ghosn, Constance Delaugerre, Philippe Flandre, Julie Galimand, Isabelle Cohen-Codar

PLoS One· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial.
Sami Kolta, Philippe Flandre, Philippe Ngo Van, Isabelle Cohen-Codar, Marc-Antoine Valantin

Curr HIV Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial.
Véronique Avettand-Fenoel, Philippe Flandre, Marie-Laure Chaix, Jade Ghosn, Constance Delaugerre, Isabelle Cohen-Codar

J Antimicrob Chemother· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.
Constance Delaugerre, Philippe Flandre, Marie Laure Chaix, Jade Ghosn, François Raffi, Isabelle Cohen-Codar

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone.
Philippe Flandre, Constance Delaugerre, Jade Ghosn, Marie Laure Chaix, Andrzej Horban, Isabelle Cohen-Codar

Antivir Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
Bruno Spire, Fabienne Marcellin, Isabelle Cohen-Codar, Philippe Flandre, François Boue

Antivir Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
Jade Ghosn, Marie-Laure Chaix, Gilles Peytavin, Jean-Louis Bresson, Julie Galimand, Isabelle Cohen-Codar

J Antimicrob Chemother· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
Jean-François Delfraissy, Philippe Flandre, Constance Delaugerre, Jade Ghosn, Andrzej Horban, Isabelle Cohen-Codar

AIDS· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients.
Martin S King, Richard Rode, Isabelle Cohen-Codar, Vincent Calvez, Anne-Geneviève Marcelin

Antimicrob Agents Chemother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Anne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, Philippe Colson, Emmanuel Guillevic

Antimicrob Agents Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis